Liquid biopsy analyses of circulating tumor DNA are emerging as transformative tools for colorectal cancer management, enabling disease detection, monitoring, and treatment. Here, we critically assess its evidence-based utility in current clinical practice, seeking to align physicians’ and patients’ expectations.

Clinical utility and future perspectives of liquid biopsy in colorectal cancer / G. Patelli, L. Lazzari, G. Crisafulli, A. Sartore-Bianchi, A. Bardelli, S. Siena, S. Marsoni. - In: COMMUNICATIONS MEDICINE. - ISSN 2730-664X. - 5:1(2025 Apr 24), pp. 137.1-137.6. [10.1038/s43856-025-00852-4]

Clinical utility and future perspectives of liquid biopsy in colorectal cancer

G. Patelli
Primo
;
A. Sartore-Bianchi;S. Siena
Penultimo
;
2025

Abstract

Liquid biopsy analyses of circulating tumor DNA are emerging as transformative tools for colorectal cancer management, enabling disease detection, monitoring, and treatment. Here, we critically assess its evidence-based utility in current clinical practice, seeking to align physicians’ and patients’ expectations.
Settore MEDS-09/A - Oncologia medica
   Liquid Biopsy and Gene Signature to Guide Non-Operative Management of Rectal Cancer (NO-CUT Trial) (6° anno)
   NO-CUT Trial
   FONDAZIONE AIRC PER LA RICERCA SUL CANCRO ETS
   AIRC IG 2017 ID 20685
24-apr-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
Patelli et al Communication Medicine 2025.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 899.35 kB
Formato Adobe PDF
899.35 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1164067
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 1
  • OpenAlex ND
social impact